Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 473870Generated: October 25, 2026

4-[3-(Trifluoromethyl)phenyl]-4-piperidinol → 1-[(7-bromo-2,3-dihydro-1,4-benzoxazepin-4(5H)-yl)carbonyl]-4-[3-(trifluoromethyl)phenyl]piperidin-4-ol

https://huagongshe.com/reaction/473870

Reaction equation

Participants

RoleNameHCIDCharge
Reactant4-[3-(Trifluoromethyl)phenyl]-4-piperidinolHCID 75255—
ReactantDiisopropylethylamineHCID 81531—
Reactant7-bromo-2,3-dihydro-1,4-benzoxazepine-4(5H)-carbonyl chlorideHCID 86672020—
SolventDichloromethaneHCID 6344—
SolventEthyl AcetateHCID 8857—
Product1-[(7-bromo-2,3-dihydro-1,4-benzoxazepin-4(5H)-yl)carbonyl]-4-[3-(trifluoromethyl)phenyl]piperidin-4-olHCID 69672299100%

Reaction Steps

A solution of 7-bromo-2,3-dihydro-1,4-benzoxazepine-4(5H)-carbonyl chloride (example 2) (0.400 g, 1.38 mmol), 4-(3-(trifluoromethyl)phenyl)piperidin-4-ol (0.371 g, 1.51 mmol), and diisopropylethylamine (0.535 g, 4.14 mmol) in dichloromethane (3 mL) was stirred at room temperature for 1 hour. The reaction mixture was diluted with ethyl acetate (50 mL), washed with 10% citric acid (20 mL) and brine (20 mL). The organic layer was dried over sodium sulfate. Filtration and concentration afforded 1-[(7-bromo-2,3-dihydro-1,4-benzoxazepin-4(5H)-yl)carbonyl]-4-[3-(trifluoromethyl)phenyl]piperidin-4-ol (0.688 g, 100%) as a white solid that was used without further purification. MS (EI) for C22H22BrF3N2O3: 500 (MH+).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08637499B2
Source datasetuspto-grants-2014_01
ORD IDord-3e1f61430f1a49f780df481a54dbea9d
Source noteuspto-grants-2014_01